Welcome to our dedicated page for Ensign Group SEC filings (Ticker: ENSG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Ensign Group’s dual identity as a post-acute care operator and real-estate lessor makes its SEC disclosures notoriously dense. Medicaid rate shifts, lease covenants, and facility occupancy tables create a maze for analysts who simply want to know, “How is the skilled nursing segment really performing?” Stock Titan eliminates that struggle with AI-powered summaries that turn 300-page documents into crisp insights you can absorb in minutes.
Need the latest Ensign Group quarterly earnings report 10-Q filing? It’s here, alongside an AI note that highlights reimbursement exposure by state. Curious about Ensign Group insider trading Form 4 transactions or Ensign Group Form 4 insider transactions real-time? Our platform streams them seconds after they hit EDGAR, complete with trend graphs that flag unusual buying by facility leaders. For every 8-K, you’ll see “Ensign Group 8-K material events explained” so you know exactly why a new lease or acquisition matters. And if you’re preparing deep research, the Ensign Group annual report 10-K simplified section links directly to AI-generated breakouts of segment margins, census trends, and Standard Bearer rental income.
Investors use these tools to compare quarter-over-quarter revenue, monitor Ensign Group executive stock transactions Form 4, or drill into Ensign Group proxy statement executive compensation without wading through footnotes. With real-time filing alerts, comprehensive coverage of every form, and expert analysis that translates healthcare jargon, understanding Ensign Group SEC documents with AI becomes effortless. Save hours, spot risks early, and act on data instead of digging for it—Stock Titan has already done the heavy lifting.
Barry M. Smith, a director of Ensign Group, Inc. (ENSG), reported a sale of 700 shares of the company's common stock on 10/01/2025 at a price of $172 per share. The filing shows 25,152 shares remained beneficially owned by Mr. Smith after the transaction. The Form 4 states the sale was effected under a Rule 10b5-1 trading plan adopted on July 31, 2024. The form was signed by a power of attorney on 10/03/2025.
Form 144 filed for Ensign Group, Inc. (ENSG) reports a proposed sale of 700 common shares through Fidelity Brokerage Services with an aggregate market value of $120,400, approximately 700 of the company's 57,700,157 outstanding shares, with an approximate sale date of 10/01/2025 on NASDAQ. The filing lists prior sales by the same person on 07/01/2025, 08/01/2025, and 09/02/2025, each of 700 shares with gross proceeds shown. Acquisition details show the shares were received as restricted stock vesting on 01/15/2022 and 01/18/2023 as compensation.
Uychiat Pison Marivic filed an Initial Statement of Beneficial Ownership for The Ensign Group, Inc. (ENSG) reporting direct ownership of 12,963 common shares and multiple employee stock options and restricted stock awards. Reported derivative holdings include options exercisable from 08/26/2020 through 11/06/2025 covering 17,559 shares in aggregate under various exercise prices, and unvested RSAs totaling 2,040 shares subject to five-year vesting schedules.
Chad A. Keetch, CIO, EVP and Secretary of The Ensign Group, Inc. (ENSG), reported a gift disposition of 2,820 shares of Ensign common stock on 09/05/2025. The transaction is coded as a G (gift) at $0. After the reported transaction, Mr. Keetch beneficially owns 94,800 shares directly. No derivative transactions were reported. The Form 4 was signed on 09/09/2025.
The Ensign Group director Barry M. Smith reported insider dispositions on 09/02/2025. The filing shows a sale of 700 shares at $172.06 per share and a separate 1,200-share transaction coded G (a gift), leaving the reporting person with 25,852 shares beneficially owned after these transactions. The filing states the sale was executed under a Rule 10b5-1 trading plan adopted on July 31, 2024. The Form 4 was signed by a power of attorney on behalf of the reporting person on 09/04/2025. This document records routine insider activity rather than operational or financial results.
The filer submitted a Form 144 notice for the sale of 700 shares of Common stock via Fidelity Brokerage Services, with an aggregate market value of $120,442 and an approximate sale date of 09/02/2025 on NASDAQ. The shares were acquired through restricted stock vesting on 01/15/2022 (424 shares) and 04/18/2024 (276 shares) and were paid as compensation. The filing lists three prior sales by Barry Smith in the past three months: 700 shares on 06/02/2025 for $102,557, 700 shares on 07/01/2025 for $107,436, and 700 shares on 08/01/2025 for $105,000. The notice includes the standard signature representation that the seller is not aware of undisclosed material adverse information.
The Ensign Group director Daren Shaw reported a sale of 1,000 shares of ENSG common stock on 08/15/2025 at a price of $166.17 per share. After the reported sale Mr. Shaw beneficially owned 24,526 shares directly. The filing discloses the sale was effected under a Rule 10b5-1 trading plan adopted May 7, 2025, indicating the transaction followed a pre-established written plan. The Form 4 was signed by a power of attorney on 08/19/2025.
The Ensign Group, Inc. (ENSG) Form 144 notice reports a proposed sale of 1,000 common shares through Fidelity Brokerage Services with an aggregate market value of $166,170.00, scheduled approximately 08/15/2025 on NASDAQ. The shares were acquired via restricted stock vesting on various dates (2018 and 2025) and paid as compensation. The filer disclosed prior sales of 1,999 shares on 05/15/2025 generating $290,794.53. The notice includes the required attestation about material nonpublic information.
The Ensign Group, Inc. insider disclosed an option exercise and immediate sale by CEO and director Barry Port. The reporting person exercised 2,399 employee stock options with a $15.93 exercise price and sold 2,399 shares at $160 per share on 08/08/2025 under a Rule 10b5-1 trading plan adopted May 6, 2024.
The report shows the reporting persons direct beneficial ownership after the transactions as 57,030 shares and indirect beneficial ownership of 155,300 shares held of record by trusts for Barry R. Port and spouse Michelle Port. The underlying options were granted August 31, 2016 and vested over five equal annual installments.